Effective Effectors: How T cells Access and Infiltrate the Central Nervous System

Por Congdon, Kendra L., Sanchez-Perez, Luis A., Sampson, John H.
Publicado no Pharmacol Ther (2018)

Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics

Por Sayour, Elias J, Sanchez-Perez, Luis, Flores, Catherine, Mitchell, Duane A
Publicado no J Immunother Cancer (2015)

Brain Tumor Micro-Environment and Host State — Implications for Immunotherapy

Por Tomaszewski, William, Sanchez-Perez, Luis, Gajewski, Thomas F., Sampson, John H.
Publicado no Clin Cancer Res (2019)

Chimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrence

Por Johnson, Laura A, Sanchez-Perez, Luis, Suryadevara, Carter M, Sampson, John H
Publicado no Oncoimmunology (2014)

EXTH-09. FIRST-IN-HUMAN DOSING CONSIDERATIONS OF A BISPECIFIC ANTIBODY FOR TREATING GLIOBLASTOMA

Por Schaller, Teilo, Foster, Matthew, Spasojevic, Ivan, Gedeon, Patrick, Sanchez-Perez, Luis, Sampson, John
Publicado no Neuro Oncol (2019)

Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity

Por Asprodites, Nicole, Zheng, Liqin, Geng, Degui, Velasco-Gonzalez, Cruz, Sanchez-Perez, Luis, Davila, Eduardo
Publicado em 2008

IM-12 RNA NANOPARTICLE VACCINES RE-PROGRAM HOST IMMUNITY IN FAVOR OF ENHANCED EFFECTOR RESPONSES AGAINST INTRACRANIAL MALIGNANCIES

Por Sayour, Elias, De Leon, Gabriel, Pham, Christina, Flores, Catherine, Sanchez-Perez, Luis, Mitchell, Duane
Publicado no Neuro Oncol (2015)

IMPS-36 RNA NANOPARTICLE VACCINES RE-PROGRAM HOST-IMMUNITY AGAINST GLIOBLASTOMA INDUCING THERAPEUTIC ANTI-TUMOR ACTIVITY

Por Sayour, Elias, De Leon, Gabe, Pham, Christina, Flores, Catherine, Sanchez-Perez, Luis, Mitchell, Duane
Publicado no Neuro Oncol (2015)

Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody

Por Choi, Bryan D, Gedeon, Patrick C, Sanchez-Perez, Luis, Bigner, Darell D, Sampson, John H
Publicado em 2013

Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy

Por Sanchez-Perez, Luis, Suryadevara, Carter M, Choi, Bryan D, Reap, Elizabeth A, Sampson, John H
Publicado no Oncoimmunology (2014)

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Por Riccione, Katherine, Suryadevara, Carter M., Snyder, David, Cui, Xiuyu, Sampson, John H., Sanchez-Perez, Luis
Publicado no J Vis Exp (2015)

DDIS-02. NOVEL BISPECIFIC ACTIVATOR OF MACROPHAGES FOR THE TREATMENT OF GLIOBLASTOMA

Por Salgado, Miguel, Schaller, Teilo, Gedeon, Patrick, Snyder, David, Archer, Gary, Sanchez-Perez, Luis, Sampson, John
Publicado no Neuro Oncol (2018)

Emerging immunotherapies for glioblastoma

Por Desai, Rupen, Suryadevara, Carter M., Batich, Kristen A., Harrison Farber, S., Sanchez-Perez, Luis, Sampson, John H.
Publicado no Expert Opin Emerg Drugs (2016)

IMMU-12. T-CELL THERAPIES DEMONSTRATE EFFICACY WITHOUT TOXICITY IN IMMUNOCOMPETENT MODELS OF BRAINSTEM TUMORS

Por Schuelke, Matt, Evgin, Laura, Wongthida, Phonphimon, Thompson, Jill, Kottke, Tim, Sanchez-Perez, Luis, Sampson, John, Vile, Richard
Publicado no Neuro Oncol (2018)

Checkpoint inhibition and CAR T cells for the Treatment of Glioblastoma

Por Shen, Steven H., Woroniecka, Karolina, Barbour, Andrew B., Fecci, Peter E., Sanchez-Perez, Luis, Sampson, John H.
Publicado no Expert Opin Biol Ther (2020)

First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach

Por Schaller, Teilo H, Snyder, David J, Spasojevic, Ivan, Gedeon, Patrick C, Sanchez-Perez, Luis, Sampson, John H
Publicado no J Immunother Cancer (2020)

Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma

Por Choi, Bryan D., Suryadevara, Carter M., Gedeon, Patrick C., Herndon, James E., Sanchez-Perez, Luis, Sampson, John H.
Publicado em 2013

IT-31 HARNESSING THE IMMUNOLOGIC CAPACITY OF THE LIVER AGAINST GLIOBLASTOMA MULTIFORME

Por Sayour, Elias, De Leon, Gabriel, Pham, Christina, Sanchez-Perez, Luis, Snyder, David, Kemeny, Hanna, Flores, Catherine, Mitchell, Duane
Publicado em 2014

Immunotherapy for malignant glioma

Por Suryadevara, Carter M., Verla, Terence, Sanchez-Perez, Luis, Reap, Elizabeth A., Choi, Bryan D., Fecci, Peter E., Sampson, John H.
Publicado no Surg Neurol Int (2015)

Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis

Por Choi, Bryan D., Gedeon, Patrick C., Kuan, Chien-Tsun, Sanchez-Perez, Luis, Archer, Gary E., Bigner, Darell D., Sampson, John H.
Publicado em 2013